首页> 外文OA文献 >Short Term Safety and Tolerance of Mesenchymal Stem Cells (MSC) Infusion as Cell Therapy for Patients Experiencing Treatment-Refractory Moderate Chronic Lung Allograft Dysfunction (CLAD)

【2h】

Short Term Safety and Tolerance of Mesenchymal Stem Cells (MSC) Infusion as Cell Therapy for Patients Experiencing Treatment-Refractory Moderate Chronic Lung Allograft Dysfunction (CLAD)

机译：短期安全性和间充质干细胞的耐受性（MSC）输注作为经历治疗 - 难治性中度慢性肺同种异体移植功能障碍的患者的细胞疗法（包层）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
C.A. Keller; A.L. Russell; R.C. Lefavor; C.M. Desmond; K.E. Hurst; H.A. David-Robinson; D.G. Kontras; A.C. Zubair;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Feasibility, Safety, and Tolerance of Mesenchymal Stem Cell Therapy for Obstructive Chronic Lung Allograft Dysfunction [J] . Cesar Ariel Keller, Thomas Arthur Gonwa, David Orel Hodge, Stem cells translational medicine. . 2018,第2期

机译：间充质干细胞治疗阻塞性慢性肺移植功能障碍的可行性，安全性和耐受性
2. Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy]) [J] . Bartolucci Jorge, Verdugo Fernando J., Gonzalez Paz L., Circulation research: a journal of the American Heart Association . 2017,第10期

机译：心力衰竭患者静脉内输液的安全性和功效心力衰竭患者1/2随机对照试验（RIMECARD试验[静脉内输注脐带脐带间充质干细胞的随机临床试验]）
3. Decreased Club Cell Secretory Protein in Bronchoalveolar Lavage is Associated with Chronic Lung Allograft Dysfunction (CLAD) but Not with CLAD Phenotypes [J] . Levy L., Huszti E., Tigert A., The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation . 2019,第4Suppla期

机译：支气管肺泡灌洗液中的降低的俱乐部细胞分泌蛋白与慢性肺同种异体移植功能障碍（包层）有关，但不具有包层表型
4. SELECTIVE RENAL INTRA-ARTERIAL (IA) AND NON-SELECTIVE INTRAVENOUS (IV) DELIVERY OF AUTOLOGOUS MESENCHYMAL-DERIVED STEM CELLS (MSC) IN CANINE AND FELINE PATIENTS WITHACUTE AND CHRONIC KIDNEY DISEASE [C] . Allyson Berent Conference of the American College of Veterinary Internal Medicine . 2013

机译：在犬和哺乳动物患者中，在犬和哺乳动物患者中，选择性肾内动脉（IA）和非选择性静脉内（IV）递送自体间充质衍生的干细胞（MSC）
5. Mesenchymal Stem Cell (MSC) Transplantation and Localization via Tissue Engineered Periosteum Coordinates Bone Allograft Healing. [D] . Hoffman, Michael D. 2014

机译：通过组织工程骨膜的间充质干细胞（MSC）移植和定位可以协调同种异体骨的愈合。
6. Feasibility Safety and Tolerance of Mesenchymal Stem Cell Therapy for Obstructive Chronic Lung Allograft Dysfunction [O] . Cesar Ariel Keller, Thomas Arthur Gonwa, David Orel Hodge, 2018

机译：间充质干细胞治疗阻塞性慢性肺移植功能障碍的可行性安全性和耐受性
7. Biological Effects of Mesenchymal Stem Cell (MSC) Therapy in Patients with Chronic Lung Allograft Dysfunction (CLAD) [O] . A.Z. Zubair, A.L. Russell, R.C. Lefavor, 2016

机译：间充质干细胞（MSC）治疗慢性肺同种异体移植功能障碍患者的生物学效应（包层）

Short Term Safety and Tolerance of Mesenchymal Stem Cells (MSC) Infusion as Cell Therapy for Patients Experiencing Treatment-Refractory Moderate Chronic Lung Allograft Dysfunction (CLAD)

著录项

相似文献

相关主题

期刊订阅